The present disclosure relates to the field of gene therapy and engineering of viral vectors for use in gene therapy. More specifically, it is disclosed herein adeno-associated virus vectors and expression cassettes comprising S/MAR sequences of c-Myc or IFN-β for the treatment of liver diseases, notably in neonates.
展开▼